Muscle Weakness in Myasthenia Gravis Reduced by New Treatment

by Medindia Content Team on  August 14, 2007 at 4:13 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Muscle Weakness in Myasthenia Gravis Reduced by New Treatment
A new cure has given hope for a new class of drugs to treat neurological disorders. A study published in the August 14, 2007, issue of Neurology, the medical journal of the American Academy of Neurology shows that muscle function improves with the administration of the drug, oral EN101antisense to individual with myasthenia gravis.

This new drug holds back the production of acetylcholine esterase, which is an important enzyme in the function of the neuromuscular junction, where nerves come in contact with the muscles. Antisense is a synthetic, short segment of DNA that locks onto a strand of mRNA and blocks production of specific proteins.

Show Full Article

"This is the first time we've been able to show that antisense is effective and safe when taken orally for a neurological disease," said study author Zohar Argov, MD, with Hadassah Hebrew University Medical Center in Jerusalem and member of the American Academy of Neurology. "Oral delivery of antisense has long been sought after since it is expected to improve patient compliance because daily injections won't be needed."

People with myasthenia gravis have increased fatigue and reduced strength in their voluntary muscles. Symptoms may also include a drooping eyelid, double vision, difficulty in swallowing, or slurred speech. Myasthenia gravis is believed to affect 20 out of every 100,000 people.

For the study, 16 people with myasthenia gravis were given daily doses of oral EN101 antisense for four days and monitored for one month. Four of the people later took the drug for a month.

The study found that oral antisense reduced disease severity by an average of 46 percent, with patients experiencing improved muscle function, improved swallowing time and the disappearance of a drooping eyelid. Side effects reported during the study were dryness of eyes and mouth.

Experts say this discovery may have implications beyond myasthenia gravis. "Oral antisense may become another mode of therapy in neuromuscular disease and further study is needed," said Argov. "However, these preliminary results should be evaluated with caution since this was an open label study."

Argov says further research is underway to look at the effects of this drug over a longer period of time.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

My brother had Mysthenia gravis last 12year, now he got white spot on skin by druge, i feel very bad to see my brother, he is 14 yr old, plz help us

I am a patient of myasthenia gravis since past two years. Now I am using Mestinon tablet. Do you have any treatment for this deases? Please let me know. I am a 34 yaer old female and have three children.

Acupressure, tissue salt remedies, charged water, meditation and certain yoga asanas like pranayam,changes in ur diet can address all ur symptoms. good luck.


i am petion of myasthenia gravis past two years . now i using mestinon tablet .do you have any treatment for this deases? pls let me know I AM 34 yaers old female i have three children. iam house wife,

Recommended Reading

Hypertension Premium Membership Benefits

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive